3LVV

BSO-inhibited ScGCL

3LVV の概要

• エントリーDOI: 10.2210/pdb3lvv/pdb
• 関連するPDBエントリー: 3IG5 3IG8 3LVW
• 分子名称: Glutamate--cysteine ligase, (2S)-2-amino-4-(S-butyl-N-phosphonosulfonimidoyl)butanoic acid, ADENOSINE-5'-DIPHOSPHATE, ... (6 entities in total)
• 機能のキーワード: ligase, glutathione, atp-grasp, atp-binding, glutathione biosynthesis, nucleotide-binding, phosphoprotein
• 由来する生物種: Saccharomyces cerevisiae (brewer's yeast,lager beer yeast,yeast)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 80877.78

構造登録者

Barycki, J.J.,Biterova, E.I. (登録日: 2010-02-22, 公開日: 2010-03-16, 最終更新日: 2023-09-06)

主引用文献

Biterova, E.I.,Barycki, J.J.
Structural basis for feedback and pharmacological inhibition of Saccharomyces cerevisiae glutamate cysteine ligase.
J.Biol.Chem., 285:14459-14466, 2010

PubMed Abstract: Structural characterization of glutamate cysteine ligase (GCL), the enzyme that catalyzes the initial, rate-limiting step in glutathione biosynthesis, has revealed many of the molecular details of substrate recognition. To further delineate the mechanistic details of this critical enzyme, we have determined the structures of two inhibited forms of Saccharomyces cerevisiae GCL (ScGCL), which shares significant sequence identity with the human enzyme. In vivo, GCL activity is feedback regulated by glutathione. Examination of the structure of ScGCL-glutathione complex (2.5 A; R = 19.9%, R(free) = 25.1%) indicates that the inhibitor occupies both the glutamate- and the presumed cysteine-binding site and disrupts the previously observed Mg(2+) coordination in the ATP-binding site. l-Buthionine-S-sulfoximine (BSO) is a mechanism-based inhibitor of GCL and has been used extensively to deplete glutathione in cell culture and in vivo model systems. Inspection of the ScGCL-BSO structure (2.2 A; R = 18.1%, R(free) = 23.9%) confirms that BSO is phosphorylated on the sulfoximine nitrogen to generate the inhibitory species and reveals contacts that likely contribute to transition state stabilization. Overall, these structures advance our understanding of the molecular regulation of this critical enzyme and provide additional details of the catalytic mechanism of the enzyme.

PubMed: 20220146
DOI: 10.1074/jbc.M110.104802

実験手法

X-RAY DIFFRACTION (2.2 Å)